ICD-10-PCS FY2027 code changes
Effective 2026-10-01.
Added to the code set (101)
- 028F3Z0 — Division of Aortic Valve, Percutaneous Approach, Native Leaflet
- 028F3Z1 — Division of Aortic Valve, Percutaneous Approach, Prosthetic Leaflet
- 028G3Z0 — Division of Mitral Valve, Percutaneous Approach, Native Leaflet
- 028G3Z1 — Division of Mitral Valve, Percutaneous Approach, Prosthetic Leaflet
- 0RGA0E0 — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
- 0RGA0EJ — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
- 0RGA3E0 — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
- 0RGA3EJ — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
- 0RGA4E0 — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0RGA4EJ — Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG00E0 — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
- 0SG00EJ — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
- 0SG03E0 — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
- 0SG03EJ — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
- 0SG04E0 — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG04EJ — Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG10E0 — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
- 0SG10EJ — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
- 0SG13E0 — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
- 0SG13EJ — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
- 0SG14E0 — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG14EJ — Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG30E0 — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
- 0SG30EJ — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
- 0SG33E0 — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
- 0SG33EJ — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
- 0SG34E0 — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0SG34EJ — Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
- 0W99003 — Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach
- 0W99303 — Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
- 0W99403 — Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
- 0W9B003 — Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach
- 0W9B303 — Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
- 0W9B403 — Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
- 0W9C003 — Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Open Approach
- 0W9C303 — Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
- 0W9C403 — Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
- 30233S5 — Transfusion of High-Dose Immune Globulin into Peripheral Vein, Percutaneous Approach
- 30243S5 — Transfusion of High-Dose Immune Globulin into Central Vein, Percutaneous Approach
- 3E00XGF — Introduction of Other Enzymatic/Chemical Agent into Skin and Mucous Membranes, External Approach
- 3E01XGF — Introduction of Other Enzymatic/Chemical Agent into Subcutaneous Tissue, External Approach
- 5A0527D — Assistance with Circulatory Decompression using Impeller Pump, Continuous
- 5A1D701 — Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day, Selective Cytopheresis
- 5A1D801 — Performance of Urinary Filtration, Prolonged Intermittent, 6-18 hours Per Day, Selective Cytopheresis
- 5A1D901 — Performance of Urinary Filtration, Continuous, Greater than 18 hours Per Day, Selective Cytopheresis
- B85A2ZZ — Other Imaging of Right Choroid using Fluorescing Agent
- B85B2ZZ — Other Imaging of Left Choroid using Fluorescing Agent
- B85G2ZZ — Other Imaging of Right Retinal Vessel using Fluorescing Agent
- B85H2ZZ — Other Imaging of Left Retinal Vessel using Fluorescing Agent
- X0HQ05C — Insertion of Leadless Neurostimulator Generator into Vagus Nerve, Open Approach, New Technology Group 12
- X27P3NC — Dilation of Right Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X27Q3NC — Dilation of Left Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X27R3NC — Dilation of Right Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X27S3NC — Dilation of Left Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X27T3NC — Dilation of Right Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X27U3NC — Dilation of Left Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
- X28M3DC — Division of Ventricular Septum using Transcatheter Septal Scoring Technique, Percutaneous Approach, New Technology Group 12
- X2H43MC — Insertion of Temporary Intraluminal Device, Venous Angle Decompression using Impeller Pump into Left Innominate Vein, Percutaneous Approach, New Technology Group 12
- X2RF3LC — Replacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12
- X2RG3FC — Replacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12
- X2RH0GC — Replacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12
- X2VJ3HC — Restriction of Thoracic Aorta, Ascending and Arch using Branched Intraluminal Device, Integrated System with Innominate Branch, Percutaneous Approach, New Technology Group 12
- X2VW3JC — Restriction of Thoracic Aorta, Descending using Branched Intraluminal Device, Integrated System Extension, Percutaneous Approach, New Technology Group 12
- X2VX0KC — Restriction of Thoracic Aorta, Arch using Branched Intraluminal Device, with Conical Collar, Open Approach, New Technology Group 12
- XEZ5XKC — Computer-Aided Triage and Notification for Imaging Abnormalities in Computed Tomography of Chest, Abdomen and Pelvis, New Technology Group 12
- XEZD3QC — Pericardial Cavity Access using Blunt-tip Concealed Needle with Mechanical Gripping Mechanism, Percutaneous Approach, New Technology Group 12
- XEZJ3NC — Coronary Artery Access using Image-Guided Crossing and Re-entry System, Percutaneous Approach, New Technology Group 12
- XEZU3HC — Computer-Aided Guidance for Intraprocedural Navigation using Ultrasound Imaging with Continuous Needle Tracking in Spinal Canal, Percutaneous Approach, New Technology Group 12
- XEZZXJC — High Dimensional Mixture-of-Experts Computer-aided Assessment of Inflammatory Response and Organ Function, for Notification and Triage, New Technology Group 12
- XEZZXLC — Computer-Aided Detection and Notification for Imaging Abnormalities in Echocardiography, New Technology Group 12
- XEZZXMC — Computer-Aided Detection and Notification for Abnormalities in Electrocardiogram, New Technology Group 12
- XEZZXPC — Cardiac Conduction Mechanism, Computer-aided Guidance for Three Dimensional Intraprocedural Navigation using Fluoroscopic Imaging, New Technology Group 12
- XEZZXRC — Computer-Aided Detection and Notification of Cardiac Abnormalities using Vital Signs, New Technology Group 12
- XEZZXSC — Cardiac Conduction Mechanism, Computer-aided Intraprocedural Visualization for Guidance, New Technology Group 12
- XFJB3CC — Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12
- XFJB4CC — Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12
- XFJB8BC — Inspection of Hepatobiliary Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12
- XFJD3CC — Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12
- XFJD4CC — Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12
- XFJD8BC — Inspection of Pancreatic Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12
- XHH80JC — Insertion of Contractility Modulation Device with Defibrillator Generator into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 12
- XRH10NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 12
- XRH13NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Approach, New Technology Group 12
- XRH14NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
- XRH20NC — Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Open Approach, New Technology Group 12
- XRH23NC — Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Approach, New Technology Group 12
- XRH24NC — Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 12
- XRH40NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Open Approach, New Technology Group 12
- XRH43NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12
- XRH44NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
- XRH60NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 12
- XRH63NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12
- XRH64NC — Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
- XW0134C — Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12
- XW0336C — Introduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12
- XW0337C — Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12
- XW0436C — Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12
- XW0Q35C — Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12
- XW0U0CC — Introduction of Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold into Joints, Open Approach, New Technology Group 12
- XW0V0BC — Introduction of Vancomycin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 12
- XXE2XHC — Measurement of Cardiac Conduction Mechanism, Computer-aided Mapping for Planning, New Technology Group 12
Removed from the code set (38)
- X2KB317 — Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7
- X2KC317 — Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7
- XD2G4V7 — Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7
- XD2G8V7 — Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7
- XD2H4V7 — Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7
- XD2H8V7 — Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7
- XRGA0R7 — Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
- XRGA3R7 — Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
- XRGA4R7 — Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
- XRGB0R7 — Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
- XRGB3R7 — Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
- XRGB4R7 — Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
- XRGC0R7 — Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
- XRGC3R7 — Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
- XRGC4R7 — Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
- XRGD0R7 — Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
- XRGD3R7 — Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
- XRGD4R7 — Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
- XW00X27 — Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7
- XW01397 — Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
- XW01X27 — Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7
- XW023X7 — Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
- XW03367 — Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW03377 — Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW033B7 — Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW04367 — Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW04377 — Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7
- XW04387 — Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW043B7 — Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7
- XW0DXR7 — Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
- XW0G7R7 — Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
- XW0H7R7 — Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7
- XW133D7 — Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133F8 — Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW143D7 — Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XXE5XR7 — Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7
- XXE5XT7 — Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7
Description revised (3)
- XW0E33B — Introduction of DB-OTO via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11 → Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
- XW0V0P7 — Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7 → Introduction of Gentamicin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
- XW143F8 — Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8 → Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8